SG Americas Securities, LLC - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 118 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$1,938
+700.8%
75,845
+652.0%
0.02%
+633.3%
Q1 2023$242
-99.9%
10,086
-55.5%
0.00%
-25.0%
Q2 2022$357,000
+61.5%
22,678
+280.2%
0.00%
+300.0%
Q4 2021$221,000
-68.7%
5,965
-59.6%
0.00%
-66.7%
Q3 2021$706,000
+132.2%
14,767
+100.8%
0.00%
+50.0%
Q1 2021$304,000
-60.5%
7,355
-59.0%
0.00%
-60.0%
Q3 2020$769,000
+122.9%
17,931
+143.0%
0.01%
+66.7%
Q2 2020$345,0007,3800.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q3 2022
NameSharesValueWeighting ↓
DFPG INVESTMENTS, LLC 456,390$5,541,0003.62%
DAFNA Capital Management LLC 173,914$1,890,0000.65%
One68 Global Capital, LLC 19,861$216,0000.47%
Diametric Capital, LP 51,982$565,0000.41%
ARK Investment Management 1,383,756$15,041,0000.38%
EAM Investors, LLC 52,833$574,0000.13%
HIGHLINE CAPITAL MANAGEMENT, L.P. 31,404$341,0000.05%
Nikko Asset Management Americas, Inc. 280,548$3,050,0000.05%
MGO ONE SEVEN LLC 14,900$161,0000.04%
Qube Research & Technologies Ltd 67,702$736,0000.02%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders